Analysis of Functional Domains of Tissue Factor Pathway Inhibitor
组织因子途径抑制剂的功能域分析
基本信息
- 批准号:09680606
- 负责人:
- 金额:$ 1.73万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:1997
- 资助国家:日本
- 起止时间:1997 至 1998
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
(1) Degradation of TFPI by thrombinIt has been shown that TFPI exists in plasma as a free-form and liporptoein-associated forms and also as truncated forms which were caused by proteolysis. We investigated the actions of various proteases on recombinant TFPI and found that thrombin inactivated the functions of TFPI by secific cleavage of three peptide bonds of TFPI(2) Interaction of TFPI with heparinWe analyzed the interaction of TEPI with heparin by using modified heparin in which N-sulafate, 2-0-sulfate or 6-0-sulfate residues were specifically removed.and by using shorter chains of polysaccharide. The results indicate that all sulfate residues are essential for the interaction and that sugar chain with 14 units has almost the same ability to interact with TFPI as heparin. We also investigated the interaction of two heparin binding sites of TFPI with heparin. We found that Arg257 and Arg259 were essential for the interaction with heparin by using synthetic peptides with C-terminal basic part. We isolated recombinant K3 domain by Baculo virus system and examined the interaction with heparin.
(1)凝血酶对TFPI的降解已表明,TFPI在血浆中存在作为自由形式和脂肪蛋白相关的形式,也是由蛋白水解引起的截断形式。我们研究了各种蛋白酶对重组TFPI的作用,发现凝血酶通过将TFPI的三种肽键(2)与肝素相互作用的TFPI(2)相互作用的三种肽键(2)与肝素与肝素的相互作用分析N-Sulate-Sulate-Sulate-Sulate-Sulate-Sulate-Sulate-S-0-0-0-0-0-0-0-0-0-0-0--0--专门删除。使用较短的多糖链。结果表明,所有硫酸盐残基对于这种相互作用都是必不可少的,并且具有14个单位的糖链与TFPI相互作用的能力与肝素相同。我们还研究了TFPI的两个肝素结合位点与肝素的相互作用。我们发现ARG257和ARG259通过将合成肽与C末端碱性部分使用,对于与肝素相互作用至关重要。我们通过Baculo病毒系统分离了重组K3结构域,并检查了与肝素的相互作用。
项目成果
期刊论文数量(9)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
N Ohkura: "A novel degradation pathway of tissue factor pathway inhibitor : Incorporation into fibrin clot and degradation by thrombin." BLOOD. 90. 1883-1892 (1997)
N Ohkura:“组织因子途径抑制剂的一种新的降解途径:掺入纤维蛋白凝块并被凝血酶降解。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
N Ohkuru: "A novel degradation pathway of tissue factor pathway inhibitor : Incorporation into fibrin clot and degradation by thrombin." BLOOD. 90. 1883-1892 (1997)
N Ohkuru:“组织因子途径抑制剂的一种新的降解途径:掺入纤维蛋白凝块并被凝血酶降解。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Z Ye: "Structural requirements of human tissue factor pathway inhibitor(TFPI)and heparin for TFPI-heparin interaction." Thromb Res. 89. 263-270 (1998)
Z Ye:“人组织因子途径抑制剂(TFPI)和肝素对 TFPI-肝素相互作用的结构要求。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Naoki Ohkura: "A novel degradation pathway of tissue factor pathway inhibitor : Incorporation into fibrin clot and clegradation by thrombin" Blood. 90(5). 1883-1892 (1997)
Naoki Ohkura:“组织因子途径抑制剂的新型降解途径:掺入纤维蛋白凝块并通过凝血酶降解”血液。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
共 8 条
- 1
- 2
KATO Hisao的其他基金
Study of chaotic dynamical systems by use of geometric topology
利用几何拓扑研究混沌动力系统
- 批准号:2254006522540065
- 财政年份:2010
- 资助金额:$ 1.73万$ 1.73万
- 项目类别:Grant-in-Aid for Scientific Research (C)Grant-in-Aid for Scientific Research (C)
Study of dynamical and geometrical properties of maps on separable metric spaces
可分离度量空间上映射的动力学和几何性质的研究
- 批准号:1954006319540063
- 财政年份:2007
- 资助金额:$ 1.73万$ 1.73万
- 项目类别:Grant-in-Aid for Scientific Research (C)Grant-in-Aid for Scientific Research (C)
Study of chaotic maps and complicated invariant sets in topological dynamics by using continuum theory
利用连续统理论研究拓扑动力学中的混沌映射和复杂不变量集
- 批准号:1454006014540060
- 财政年份:2002
- 资助金额:$ 1.73万$ 1.73万
- 项目类别:Grant-in-Aid for Scientific Research (C)Grant-in-Aid for Scientific Research (C)
Research of invariant sets of topological dynamics in continuum theory
连续介质理论中拓扑动力学不变集的研究
- 批准号:1164005811640058
- 财政年份:1999
- 资助金额:$ 1.73万$ 1.73万
- 项目类别:Grant-in-Aid for Scientific Research (C)Grant-in-Aid for Scientific Research (C)
Development of a novel method for anticoagulant property of vascular endothlial cells and its application to the diagnosis of cardiovascular diseases
血管内皮细胞抗凝特性的新方法开发及其在心血管疾病诊断中的应用
- 批准号:1055709510557095
- 财政年份:1998
- 资助金额:$ 1.73万$ 1.73万
- 项目类别:Grant-in-Aid for Scientific Research (B)Grant-in-Aid for Scientific Research (B)
The mechanism of the initiation ractions for the intrinsic blood coagulation,kinin release and fibrinolysis: the activation mechanism of the precursor of serine proteases by negatively-charged surfaces and gheir biological significance.
内在凝血、激肽释放和纤溶的起始反应机制:带负电表面的丝氨酸蛋白酶前体的激活机制及其生物学意义。
- 批准号:6148046261480462
- 财政年份:1986
- 资助金额:$ 1.73万$ 1.73万
- 项目类别:Grant-in-Aid for General Scientific Research (B)Grant-in-Aid for General Scientific Research (B)
相似国自然基金
基于炎症与血液高凝状态的关联研究促孕复方改善胚胎着床障碍及早期妊娠丢失的分子机制
- 批准号:81874388
- 批准年份:2018
- 资助金额:56.0 万元
- 项目类别:面上项目
阿加曲班改性滤器膜通过凝血酶介导的补体C5a/C5aR通路影响微炎症形成的机制研究
- 批准号:81800680
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
核壳模板-溶胀破壳法构筑类肝素结构凝胶微球
- 批准号:51773127
- 批准年份:2017
- 资助金额:55.0 万元
- 项目类别:面上项目
FⅡa-polyP-FⅫ级联反应在血液净化凝血中的作用及AG抗凝滤器对其影响
- 批准号:81670693
- 批准年份:2016
- 资助金额:58.0 万元
- 项目类别:面上项目
血小板FVIII基因治疗诱导血友病A小鼠FVIII免疫耐受研究
- 批准号:81500158
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Mechanisms of cancer immunotherapy-associated thrombosis
癌症免疫治疗相关血栓形成的机制
- 批准号:1066704610667046
- 财政年份:2023
- 资助金额:$ 1.73万$ 1.73万
- 项目类别:
PAR4 mediates platelet activation in venous thromboembolism
PAR4介导静脉血栓栓塞中的血小板活化
- 批准号:1038730210387302
- 财政年份:2022
- 资助金额:$ 1.73万$ 1.73万
- 项目类别:
Lead identification and pre-clinical studies on allosteric inhibitors of coagulation factor XIa
凝血因子 XIa 变构抑制剂的先导化合物鉴定和临床前研究
- 批准号:1036939410369394
- 财政年份:2022
- 资助金额:$ 1.73万$ 1.73万
- 项目类别:
Protein S Regulates Blood Coagulation by Inhibiting Factor IXa
Protein S 通过抑制 IXa 因子调节凝血
- 批准号:1061673210616732
- 财政年份:2022
- 资助金额:$ 1.73万$ 1.73万
- 项目类别:
PAR4 mediates platelet activation in venous thromboembolism
PAR4介导静脉血栓栓塞中的血小板活化
- 批准号:1079492010794920
- 财政年份:2022
- 资助金额:$ 1.73万$ 1.73万
- 项目类别: